These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 8137757
21. Thyroid hormone receptor monomer, homodimer, and heterodimer (with retinoid-X receptor) contact different nucleotide sequences in thyroid hormone response elements. Ikeda M, Rhee M, Chin WW. Endocrinology; 1994 Oct; 135(4):1628-38. PubMed ID: 7925126 [Abstract] [Full Text] [Related]
23. Vitamin D3-thyroid hormone receptor heterodimer polarity directs ligand sensitivity of transactivation. Schräder M, Müller KM, Nayeri S, Kahlen JP, Carlberg C. Nature; 1994 Aug 04; 370(6488):382-6. PubMed ID: 8047145 [Abstract] [Full Text] [Related]
24. N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone. Ng L, Forrest D, Haugen BR, Wood WM, Curran T. Mol Endocrinol; 1995 Sep 04; 9(9):1202-13. PubMed ID: 7491112 [Abstract] [Full Text] [Related]
25. Roles of 3,5,3'-triiodothyronine and deoxyribonucleic acid binding on thyroid hormone receptor complex formation. Yen PM, Brubaker JH, Apriletti JW, Baxter JD, Chin WW. Endocrinology; 1994 Mar 04; 134(3):1075-81. PubMed ID: 8119145 [Abstract] [Full Text] [Related]
26. The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements. Desai-Yajnik V, Samuels HH. Mol Cell Biol; 1993 Aug 04; 13(8):5057-69. PubMed ID: 8393143 [Abstract] [Full Text] [Related]
27. T3 receptor suppression of Sp1-dependent transcription from the epidermal growth factor receptor promoter via overlapping DNA-binding sites. Xu J, Thompson KL, Shephard LB, Hudson LG, Gill GN. J Biol Chem; 1993 Jul 25; 268(21):16065-73. PubMed ID: 8393457 [Abstract] [Full Text] [Related]
28. The effects of P-box substitutions in thyroid hormone receptor on DNA binding specificity. Nelson CC, Hendy SC, Faris JS, Romaniuk PJ. Mol Endocrinol; 1994 Jul 25; 8(7):829-40. PubMed ID: 7984145 [Abstract] [Full Text] [Related]
29. A shift in the ligand responsiveness of thyroid hormone receptor alpha induced by heterodimerization with retinoid X receptor alpha. Claret FX, Antakly T, Karin M, Saatcioglu F. Mol Cell Biol; 1996 Jan 25; 16(1):219-27. PubMed ID: 8524299 [Abstract] [Full Text] [Related]
30. Differential sensitivity of thyroid hormone receptor isoform homodimers and mutant heterodimers to hormone-induced dissociation from deoxyribonucleic acid: its role in dominant negative action. Zhu XG, McPhie P, Cheng SY. Endocrinology; 1997 Apr 25; 138(4):1456-63. PubMed ID: 9075702 [Abstract] [Full Text] [Related]
31. Dominant negative activity of mutant thyroid hormone alpha1 receptors from patients with hepatocellular carcinoma. Lin KH, Zhu XG, Hsu HC, Chen SL, Shieh HY, Chen ST, McPhie P, Cheng SY. Endocrinology; 1997 Dec 25; 138(12):5308-15. PubMed ID: 9389515 [Abstract] [Full Text] [Related]
32. 3,5,3'-triiodothyronine (T3) receptor-auxiliary protein (TRAP) binds DNA and forms heterodimers with the T3 receptor. Darling DS, Beebe JS, Burnside J, Winslow ER, Chin WW. Mol Endocrinol; 1991 Jan 25; 5(1):73-84. PubMed ID: 1850111 [Abstract] [Full Text] [Related]
33. Structure-function relationship of the inhibition of the 3,5,3'-triiodothyronine binding to the alpha1- and beta1-thyroid hormone receptor by amiodarone analogs. van Beeren HC, Bakker O, Wiersinga WM. Endocrinology; 1996 Jul 25; 137(7):2807-14. PubMed ID: 8770901 [Abstract] [Full Text] [Related]
34. Divergent dimerization properties of mutant beta 1 thyroid hormone receptors are associated with different dominant negative activities. Hao E, Menke JB, Smith AM, Jones C, Geffner ME, Hershman JM, Wuerth JP, Samuels HH, Ways DK, Usala SJ. Mol Endocrinol; 1994 Jul 25; 8(7):841-51. PubMed ID: 7984146 [Abstract] [Full Text] [Related]
35. Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression. Qi JS, Desai-Yajnik V, Yuan Y, Samuels HH. Mol Cell Biol; 1997 Dec 25; 17(12):7195-207. PubMed ID: 9372952 [Abstract] [Full Text] [Related]
36. Thyroid hormone receptor mutations that interfere with transcriptional activation also interfere with receptor interaction with a nuclear protein. O'Donnell AL, Rosen ED, Darling DS, Koenig RJ. Mol Endocrinol; 1991 Jan 25; 5(1):94-9. PubMed ID: 1850112 [Abstract] [Full Text] [Related]
37. Calcitriol down-modulates the 3,5,3' triiodothyronine (T3) receptors and affects, in a biphasic manner, the T3-dependent adipose differentiation of Ob 17 preadipocytes. Lenoir C, Dace A, Martin C, Bonne J, Teboul M, Planells R, Torresani J. Endocrinology; 1996 Oct 25; 137(10):4268-76. PubMed ID: 8828486 [Abstract] [Full Text] [Related]
38. Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator. Desai-Yajnik V, Hadzic E, Modlinger P, Malhotra S, Gechlik G, Samuels HH. J Virol; 1995 Aug 25; 69(8):5103-12. PubMed ID: 7609079 [Abstract] [Full Text] [Related]
39. Identification of a thyroid hormone response element in the mouse myogenin gene: characterization of the thyroid hormone and retinoid X receptor heterodimeric binding site. Downes M, Griggs R, Atkins A, Olson EN, Muscat GE. Cell Growth Differ; 1993 Nov 25; 4(11):901-9. PubMed ID: 8297796 [Abstract] [Full Text] [Related]
40. Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity. Saatcioglu F, Lopez G, West BL, Zandi E, Feng W, Lu H, Esmaili A, Apriletti JW, Kushner PJ, Baxter JD, Karin M. Mol Cell Biol; 1997 Aug 25; 17(8):4687-95. PubMed ID: 9234725 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]